Extensive analysis of signaling pathway molecules in breast cancer: association with clinicopathological characteristics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Extensive analysis of signaling pathway molecules in breast cancer: association with clinicopathological characteristics

Published:2014-10-15 Issue:3 Volume:20 Page:490-498
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Horii Rie,Matsuura Masaaki,Dan Shingo,Ushijima Masaru,Uehiro Natsue,Ogiya Akiko,Honma Naoko,Ito Yoshinori,Iwase Takuji,Yamori Takao,Akiyama Futoshi

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-014-0753-8.pdf

Reference24 articles.

1. Vogelstein B, Papadopoulos N, Velculescu VE et al (2013) Cancer genome landscapes. Science 339:1546–1558

2. Kong D, Yamori T (2008) Phosphatidylinositol 3-kinase inhibitors: promising drug candidates for cancer therapy. Cancer Sci 99:1734–1740

3. Di Nicolantonio F, Arena S, Tabernero J et al (2010) Deregulation of the PI3 K and KRAS signaling pathways in human cancer cells determines their response to everolimus. J Clin Invest 120:2858–2866

4. Bollag G, Hirth P, Tsal J et al (2010) Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature 467:596–599

5. Serra V, Markman B, Scaltriti M et al (2008) NVP-BEZ235, a dual PI3 K/mTOR inhibitor, prevents PI3 K signaling and inhibits the growth of cancer cells with activating PI3 K mutations. Cancer Res 68:8022–8030

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hierarchical clustering of PI3K and MAPK pathway proteins in breast cancer intrinsic subtypes;APMIS;2020-02-27

2. The Prognostic Role of Ribosomal Protein S6 Kinase 1 Pathway in Patients With Solid Tumors: A Meta-Analysis;Frontiers in Oncology;2019-05-14

3. Hierarchical clustering of activated proteins in the PI3K and MAPK pathways in ER-positive, HER2-negative breast cancer with potential therapeutic consequences;British Journal of Cancer;2018-10

4. RET Signaling in Prostate Cancer;Clinical Cancer Research;2017-05-10

5. Twist1-mediated 4E-BP1 regulation through mTOR in non-small cell lung cancer;Oncotarget;2015-08-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3